ALNY Alnylam Pharmaceuticals, Inc.
ALNY Alnylam Pharmaceuticals, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-14 1 bear converging
POC $452.13 · VWAP $351.48 · -36.1% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
ALNY Price Structure
Loading timeframes…
Peers
Every watchlist ALNY belongs to, members best 30-day change first — ALNY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $1.29B, diluted EPS $1.21, net income $164M (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved -28.3% (close before → first close after).
full note →Against street estimates
How ALNY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about ALNY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 18 days ago · Jul 31
- Dimensional Fund Advisors LP Purchases 82,340 Shares of Alnylam Pharmaceuticals, Inc. (ALNY)
- Orbimed Advisors LLC Sells 169,800 Shares of Alnylam Pharmaceuticals, Inc. (ALNY)
- Entropy Technologies LP Boosts Holdings in Alnylam Pharmaceuticals, Inc. (ALNY)
- Alnylam Pharmaceuticals, Inc. (ALNY) Shares Purchased by First Trust Advisors LP
- JPMorgan Chase & Co. Has Lowered Expectations for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price
ALNY research tape
47 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.